Delivery Order SPE2DB20D9331-SPE2DB21FL1F2

Award Date 5/28/21
Potential Completion Date 6/1/21
Potential Value $1.5K
Ultimate Awardee
Not listed
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Park Ridge, IL 60068, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
The U.S. Defense Logistics Agency (DLA) awarded a firm fixed-price delivery order contract to DMS Pharmaceutical Group Inc., a woman-owned small business, to provide a wide range of pharmaceutical products and medical supplies to support the recurring medical needs of military health facilities worldwide. The contract, valued at $1,221.12, is part of DMS Pharmaceutical Group's larger indefinite delivery contract (IDC) with the DLA under the SPE2DB program, which has a ceiling value of up to...
This contract award to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler, is a delivery order under the Defense Logistics Agency's (DLA) SPE2DB program. DMS Pharmaceutical Group will provide a wide range of pharmaceutical products, including branded and generic prescription drugs, over-the-counter medications, biologics, and medical consumables, to support the recurring medical supply needs of military health facilities worldwide. The contract has a ceiling...
This federal contract award to DMS Pharmaceutical Group Inc., a woman-owned small business, is a delivery order under the Defense Logistics Agency's (DLA) SPE2DB program. The order, valued at $11,006.95, is for the provision of a wide range of pharmaceutical products, including branded and generic prescription drugs, over-the-counter medications, biologics, and medical consumables, to support the recurring medical supply needs of military health facilities and VA medical centers nationwide....
This contract awarded to DMS Pharmaceutical Group Inc., a woman-owned small business, is a delivery order under the Defense Logistics Agency's (DLA) SPE2DB program, which is a single-award Indefinite Delivery Contract (IDC) valued up to $499,999,999. The contract covers the supply of a comprehensive range of pharmaceutical items, including branded and generic prescription drugs, over-the-counter medications, biologics, and medical consumables, to support the recurring medical supply needs of...
The Defense Logistics Agency (DLA) awarded a firm fixed-price delivery order contract to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler, to provide a wide range of pharmaceutical products and medical supplies to support the medical needs of military health facilities worldwide. The contract, valued at up to $12,508.75, covers the delivery of various medications and medical consumables, including branded and generic prescription drugs, over-the-counter...
This federal contract award to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler, is a Firm Fixed Price delivery order worth $17,614.47 under the Defense Logistics Agency's (DLA) SPE2DB program. The contract covers the supply of a range of pharmaceutical products, including branded and generic prescription drugs, over-the-counter medications, biologics, and medical consumables, to support the recurring medical supply needs of military health facilities...
This federal contract award to DMS Pharmaceutical Group Inc., a woman-owned small business, is a delivery order under the Defense Logistics Agency's (DLA) SPE2DB program. The $17,614.47 firm fixed-price contract is for the prime vendor supply of a wide range of pharmaceutical products, including branded and generic prescription drugs, over-the-counter medications, biologics, and medical consumables, to support the recurring medical supply needs of military health facilities and Department of...
This contract award to DMS Pharmaceutical Group Inc., a woman-owned small business, is a $2,571.84 firm fixed-price delivery order under the Defense Logistics Agency's (DLA) SPE2DB pharmaceutical prime vendor program. The contract provides a wide range of pharmaceutical products, including branded and generic prescription drugs, over-the-counter medications, biologics, and medical consumables, to support the recurring medical supply needs of military health facilities worldwide. DMS...
This federal contract award to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler, is a delivery order valued at $25,929.00 for the provision of a wide range of pharmaceutical products and medical supplies to support the medical needs of military health facilities. The contract was awarded by the Defense Logistics Agency (DLA), a defense agency, and is part of the DLA's Medical Supply Chain division. The contract has no set-aside designation and is a firm...
This federal contract award to DMS Pharmaceutical Group Inc., a woman-owned small business, is a delivery order valued at $24,948.60 under the DLA's SPE2DB program. The contract is for the supply of various pharmaceutical products, including branded and generic prescription drugs, over-the-counter medications, biologics, and medical consumables, to support the recurring medical supply needs of military health facilities worldwide. The contract has a firm fixed-price pricing type and no set-aside...
  • SPE2DB20D9331
    Indefinite Delivery Contract
  • SPE2DB20D9331-SPE2DB21FL1F2
    Delivery Order

This contract award to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler, is a delivery order worth $1,540.90 under the Defense Logistics Agency's (DLA) SPE2DB program. The order is for a range of pharmaceutical products, including branded and generic prescription drugs, over-the-counter medications, biologics, and medical consumables, to support the recurring medical supply needs of military health facilities worldwide. DMS Pharmaceutical Group holds a larger indefinite delivery contract (IDC) with the DLA under the SPE2DB program, valued at up to $499,999,999, which runs through December 31, 2025. This single-award IDC allows the DLA to issue firm fixed-price delivery orders for a comprehensive array of pharmaceutical items to fulfill the diverse medical requirements of the Department of Defense healthcare system. The contract has no set-aside designation.

Generated 1/9/25, 9:23 AM